JPS60147650A - Formation of supernatant liquid from specimen - Google Patents

Formation of supernatant liquid from specimen

Info

Publication number
JPS60147650A
JPS60147650A JP449084A JP449084A JPS60147650A JP S60147650 A JPS60147650 A JP S60147650A JP 449084 A JP449084 A JP 449084A JP 449084 A JP449084 A JP 449084A JP S60147650 A JPS60147650 A JP S60147650A
Authority
JP
Japan
Prior art keywords
cells
specimen
cell
carrier
lectin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP449084A
Other languages
Japanese (ja)
Other versions
JPH0416744B2 (en
Inventor
Kyuji Mutsukawa
六川 玖治
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toshiba Corp
Original Assignee
Toshiba Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toshiba Corp filed Critical Toshiba Corp
Priority to JP449084A priority Critical patent/JPS60147650A/en
Publication of JPS60147650A publication Critical patent/JPS60147650A/en
Publication of JPH0416744B2 publication Critical patent/JPH0416744B2/ja
Granted legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5002Partitioning blood components

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

PURPOSE:To remove easily and quickly unnecessary cells, etc. from the inside of a specimen contg. cells without the need for intricate machines and instruments by bringing a carrier fixed with cell agglutinin and said specimen into contact with each other. CONSTITUTION:Cell agglutinum such as concanavalin A, leukoavalutinin or the like is fixed to a carrier of a water soluble high polymer material such as polystyrene, agar or the like or an inorg. material such as glass or the like which can fix stably the cell agglutinin without spoiling the activity thereof. The cell agglutinin fixed to the carrier is brought into contact with a specimen contg. cells such as blood, lymph fluid, bodily vaginal fluid, urine or the like drawn from a patient. The supernatant from which the unnecessary cells, etc. removed is thus formed in short time without requiring intricate machines and instruments.

Description

【発明の詳細な説明】 〔発明の技術分野〕 この発明は、検体中から不要な細胞管を除去して上澄液
を生成する方法に関する。
DETAILED DESCRIPTION OF THE INVENTION [Technical Field of the Invention] The present invention relates to a method for removing unnecessary cell tubes from a specimen to produce a supernatant.

〔発明の技術的背景とその問題点〕[Technical background of the invention and its problems]

臨床検査どして生化学分析や免疫分析をtjなう場合、
被検体たとえば患者より採取した血液、体腔液、尿等の
各種細胞を含有する検体の上澄液を検査試料とすること
が多い。また、血清学分野において、免疫反応の前処理
として、検体に赤血球ゴースト膜や固定赤血球を添加す
ることにより検体中の非特異性抗体を除去して、その十
澄液を免疫反応に供する場合゛bある。(41物化学実
験法15巻P、112学会出版センター(1981))
いずれにおいても、検体から−[澄液を生成し、これを
採取する必要がある。上澄液の生成法どして、遠心分離
を行なう1j法あるいはメンブランフィルタ等による濾
過を行なう方法が一般的である。
When performing biochemical analysis or immunological analysis as part of a clinical test,
The test sample is often a supernatant fluid of a specimen, such as blood, body cavity fluid, urine, etc., collected from a patient and containing various cells. In addition, in the field of serology, non-specific antibodies in the specimen are removed by adding red blood cell ghost membranes or fixed red blood cells to the specimen as a pretreatment for the immune reaction, and the resulting clear liquid is used for the immune reaction. There is b. (41 Physical Chemistry Experimental Methods Vol. 15 P, 112 Gakkai Publishing Center (1981))
In either case, it is necessary to generate and collect a clear liquid from the specimen. The general method for producing the supernatant liquid is the 1j method involving centrifugation or filtration using a membrane filter or the like.

しかしながら、前記のような上澄液の生成法は、確実で
有効であるが、特別な機械、器具を必要とし、かつ、手
間と時間がかかる。ま/j、メンブランフィルタを使用
する場合は、細胞又は細胞破片による目詰りが重要イf
問題であり、史にコストが多くかる。
However, although the method for producing supernatant liquid as described above is reliable and effective, it requires special machines and equipment, and is laborious and time-consuming. When using membrane filters, clogging with cells or cell debris is an important issue.
This is a problem and costs a lot of history.

一方、自然弄にG、L、細胞、特に赤血球を強く凝集さ
せる物質が数多く存在する。これら物質を総称してレク
チンと6われでいる。レクチン自体は糖タンパク質であ
り、細胞表層における各種糖鎖を認識して、そこに吸着
するので、細胞同志を凝−果させるのであると考えられ
る。この様なレクチンの性質を利用する技術として、ア
フィニiイクロマトグラフイーによる細胞分画法がある
。この方法は、たとえばデキストランピースの表面に各
種のレクチンを固定し、次い(その、−キス1、ランビ
ーズを充IRづ゛るカラムに、各種細胞を含有する試料
を流下させ、レクチンに対する細胞の親和性の相違にJ
、す、試r1中の各種ff1l胞を分画し、目的とする
特定細胞を得る。各種レクチンを固定したデキストラン
ピースは、たとえばスウ[−デンのファルマシア祝野に
り市販されていC1商業的に入手可能である。
On the other hand, there are many substances that naturally cause strong agglutination of G, L, cells, especially red blood cells. These substances are collectively called lectins. Lectin itself is a glycoprotein that recognizes various sugar chains on the cell surface and adsorbs there, which is thought to cause cells to aggregate. As a technique that utilizes such properties of lectins, there is a cell fractionation method using affinity i chromatography. In this method, for example, various lectins are immobilized on the surface of a dextran piece, and then a sample containing various cells is allowed to flow down an IR column filled with dextran beads. J due to differences in affinity
Then, the various ff1l cells in trial r1 are fractionated to obtain the desired specific cells. Dextran pieces on which various lectins are immobilized are commercially available, for example, from Pharmacia Shoninori of Sueden and commercially available as C1.

前記レクチンのほかに、細胞凝抹素として、当該細胞を
抗原として認識する抗体がある。この抗体を利用する技
術として、血液凝14Fシ応を利用する血液型判定等が
ある。
In addition to the lectins, there are antibodies that recognize the cells as antigens, which are called cell aggregins. Techniques using this antibody include blood type determination using 14F blood coagulation reaction.

そこで、検体から上澄液を15するlこめに、検体に、
レクチンあるいは特定の抗体を単体のまま添加り−るこ
とにより、検体中のたとえば赤血球細胞を凝集させる方
法が考えられる。
Therefore, after diluting 15 l of supernatant from the specimen,
One possible method is to agglutinate, for example, red blood cells in a specimen by adding a lectin or a specific antibody as a single substance.

しかしながら、過剰のや当該抗体が上澄液中に残留する
ことがあり、上澄液中にレクチン笠が残留すると、次に
行なJ3うとする検査に悪影響が及はされてしまう。!
ことえば、溶血素測定の場合、反応系には羊赤血球、溶
血素(抗羊赤血球坑体)及び補体が含まれる。この場合
の補体とはモルモットの血清を指している。モル七ツ1
〜血清中には元来、異好抗体、例えばフォルスマン抗体
が含まれておりそのまま使用すると溶血素の有無に拘ら
ず羊赤血球を溶血さt!てしまう。そこで、事前にモル
モット血清と、固定羊赤血球(羊赤血球膜をグルタルア
ルデヒド等で処理し、溶血しない様にしたもの)、また
は羊赤血球のゴースト膜等をインキコベートし、[ルモ
ット血清中のy<好抗体を吸着させる作業が行われる。
However, excess lectin antibodies may remain in the supernatant, and if lectin caps remain in the supernatant, the next J3 test will be adversely affected. !
For example, in the case of hemolysin measurement, the reaction system includes sheep red blood cells, hemolysin (anti-sheep red blood cell antibody), and complement. Complement in this case refers to guinea pig serum. Mol Nanatsu 1
~Serum originally contains heterophilic antibodies, such as Forsmann antibodies, and if used as is, it will hemolyze sheep red blood cells regardless of the presence or absence of hemolysin! I end up. Therefore, in advance, guinea pig serum and fixed sheep red blood cells (sheep red blood cell membranes treated with glutaraldehyde etc. to prevent hemolysis) or ghost membranes of sheep red blood cells, etc. Work to adsorb antibodies is performed.

この時、固定赤血球及びゴースト膜の分離にレクチンを
応用リ−る事ができるが、上澄面清中に過剰のレクチン
が残留すると、次段反応、即ち溶面反応の際、イ赤血球
が凝集してしまい、反応の効率及び宙吊に支障をきたし
−(しまう。
At this time, lectins can be applied to separate fixed red blood cells and ghost membranes, but if excess lectin remains in the supernatant, red blood cells will agglutinate during the next reaction, that is, the lysis reaction. This will impede the reaction efficiency and suspension.

〔発明の目的〕[Purpose of the invention]

この発明は、前記事情に基づいてなされたものであり、
複雑な機械、器具を使用することなく、検体中から不要
なIII胞等を簡便かつ迅速に除去づる方法を提供する
ことを目的とするものである。
This invention was made based on the above circumstances,
The object of the present invention is to provide a method for simply and quickly removing unnecessary cysts III from a specimen without using complicated machines or instruments.

(発明の概要〕 前記目的を達成するためのこの発明の概要は、細胞を含
有り−る検体と、単体に固定−りる細胞凝集素とを接触
させることを特徴とするもの(゛ある。
(Summary of the Invention) The outline of the present invention for achieving the above object is characterized in that a sample containing cells is brought into contact with a cell agglutinin that is fixed alone.

〔発明の実施例〕[Embodiments of the invention]

この発明は、細胞を含有する検体と1[1体に固定Jる
細胞凝集素とを接触させることにより細胞を凝集さけ′
で、上澄液を得る。
This invention prevents aggregation of cells by bringing a specimen containing cells into contact with a cell agglutinin fixed on the body.
Obtain the supernatant.

細胞を含有する検体として、被検体たとえば(1り者よ
り採取した血液、リンパ液、体11?il液、尿等が挙
げられる。なお、この発明におい(、細胞とは、細胞そ
れ自体のほかに、細胞膜等のIll胞ハを含むものとす
る。
Examples of specimens containing cells include blood, lymph, body fluid, urine, etc. collected from a single person. , including cells such as cell membranes.

細胞凝集素どしくは、たとえばコンカッバリンA10イ
コアバルチニン、小麦胚芽レクfン、大豆レクチン、落
花生レクチン、マツシュルームレクチン、リママメレク
ブ°ン、レンズマメレクチン、エンドウレクチン、ソラ
マメレクヂン、ジ11ガイモレクチン、ヒマレクチン、
ウプギ血消、カタツムリレクチン、肝臓から分離したガ
ラクトースを結合するタンパク賀、プロティンA1その
他各種の細菌の細胞壁に由来づるリポタンパク質重σ)
レクチン、及び、除去されるべき細胞に対りる抗体、例
えば当該細胞が羊赤血球の時は抗羊赤血球抗体、が挙げ
られる。
Cell agglutinants include, for example, concavalin A10 icobartinin, wheat germ lektin, soybean lectin, peanut lectin, pine mushroom lectin, lima bean lectin, lentil lectin, pea lectin, fava bean lectin, di-11 gyomolectin, himalectin,
Snail lectin, galactose-binding protein isolated from the liver, protein A1, and other lipoproteins derived from the cell walls of various bacteria)
Examples include lectins and antibodies directed against the cells to be removed, such as anti-sheep red blood cell antibodies when the cells are sheep red blood cells.

この発明にお(プる担体は、前記細胞凝集素を、(の活
性を損なうことイ【<安定に固定りることがC・ぎれば
どのようであってもよく、たとえばポリス−Fレン、デ
キストラン、セルロース、ポリアクリルアミド、ナイ[
Iン、寒天、デンプン、げラチン、−」ラーゲン、−1
−1〜リン箋の水不溶性高分子物質、ポリビニルアルニ
1−ル、ポリビニルピロリドン、可溶性デンプン、ポリ
アミノ酸、ポリ1チレングリ]−ル等の水溶性高分子物
質、ガラス、ステンレススチール笠の無機物質が挙げら
れる。ガラスを担体に選ぶと、たとえばガラス製のザン
ブルカップを担体とすることができ、そうすると、前記
細胞凝集素を内壁面に安定に結合するガラス製の゛リン
プルカップ内に検体を投入するだけで、検体内の細胞が
凝集し、沈降するので、トt’l液を得る処理を簡便な
”bのと覆ることができる。また、スアンレススチール
を担体に選ぶと、検体を収容づる1Jンプルカツプを磁
界内に向くことにJ、り迅速に細胞を凝集、沈降さける
ことができる。更に水不溶性高分子も又、前述の様にレ
クチンの良好な担体となりうる。しかしながらこれらの
不溶性担体を用いた場合には被検液中に浮遊りる■1胞
どレクチンの接触が限られてしまう。従って細胞除去の
観点からみれば、これら不溶[110体を使用覆る事は
、必ずしも効率的とは言えない。−乃レクチンの担体と
した水可溶性のへ分子を用いると、担体自体が水溶性で
あるので固定化されIこレクチンと、当該細胞の接触の
機会も多くなり、史に担体分子自体柔軟性を有する為、
より効率的に当該細胞を吸着する事が出来る。更にレク
チンと反応した、細胞は、凝集し沈澱するがその際周囲
におる細胞結合数の少ないレクチン固定化水溶性高分子
も取り込みつつ巨大なカタマリとなり沈澱り−る。
The carrier used in the present invention may be any carrier that can impair the activity of the cell agglutinin (for example, poly-Frene, Dextran, cellulose, polyacrylamide, nylon
In, agar, starch, geratin, -" lagen, -1
-1~Water-insoluble polymeric substances on paper, water-soluble polymeric substances such as polyvinylalnylene, polyvinylpyrrolidone, soluble starch, polyamino acids, polyethylene glycol, glass, and inorganic substances on stainless steel hats. Can be mentioned. If glass is selected as the carrier, for example, a glass zamble cup can be used as the carrier, and the sample can be collected by simply placing the sample into the glass rimple cup that stably binds the cell agglutinin to the inner wall surface. Since the cells in the sample aggregate and settle, the process for obtaining the liquid can be easily replaced with step 2.In addition, if Suanless Steel is selected as the carrier, the 1J sample cup containing the sample is exposed to the magnetic field. By directing inwards, cells can be rapidly agglomerated and sedimented.Furthermore, water-insoluble polymers can also be good carriers for lectins, as mentioned above.However, when these insoluble carriers are used, The contact of lectins floating in the test solution is limited. Therefore, from the viewpoint of cell removal, it is not necessarily efficient to cover these insoluble cells. - When a water-soluble hemomolecule is used as a carrier for lectin, since the carrier itself is water-soluble, it is immobilized and there are more opportunities for contact between the lectin and the cells, and the carrier molecule itself becomes flexible. To have,
The cells can be adsorbed more efficiently. Furthermore, the cells that have reacted with the lectin aggregate and precipitate, but at this time, they also take in the lectin-immobilized water-soluble polymer that binds to the surrounding cells in a small number of cells, and become a huge clump and precipitate.

従って、レクチンの11体としτ水溶性高分子を用いる
事により、当該細胞の除去を効率的に行なわせる事が出
来ると倶に過剰なレクチンを含まないきれいな上澄を得
ることができる。
Therefore, by using lectin 11 and a τ water-soluble polymer, the cells can be efficiently removed and a clean supernatant containing no excess lectin can be obtained.

前記担体への細胞凝集素の固定化り法は、酵素の固定化
に応用されている従来公知の方法を採用”することがで
きる。
As a method for immobilizing cell agglutinin onto the carrier, conventionally known methods applied to immobilization of enzymes can be adopted.

細胞を含有する検体と担体に固定する細胞凝集素との接
触は、たとえば検体に細胞凝集素を固定する担体を添加
することにより行なうことができる。そして、添加した
液を10℃以上、好ましくは4℃前後に冷却すると、場
合によるが、約5分〜10分で細胞を凝集、沈降させる
ことがひきる。
Contact between the specimen containing cells and the cell agglutinin immobilized on the carrier can be carried out, for example, by adding a carrier that immobilizes the cell agglutinin to the specimen. Then, when the added liquid is cooled to 10° C. or higher, preferably around 4° C., the cells can be aggregated and sedimented in about 5 to 10 minutes, depending on the case.

その結果として、添加した液の下部には沈降物が沈澱し
、上部に[−澄液が生成覆るので、この上澄液をピペッ
ト、吸引ノズル等の採取手段で分離することができる。
As a result, a precipitate settles in the lower part of the added liquid, and a clear liquid forms in the upper part, so that this supernatant liquid can be separated by a sampling means such as a pipette or a suction nozzle.

次に、この発明の実験例を承りことにより、さらにこの
発明を具体化する。
Next, the present invention will be further embodied by accepting experimental examples of the present invention.

〈実験例〉 免疫測定法(イムノアッセイ)を行なう場合、検体であ
る被検血清中にフAルスンン坑体笠の異好抗体が存在す
ると、イムノアッセイを正確に行なうことができない場
合がある。例えば、溶血素測定の際の、補体面清くモル
モツ1〜面2T’i )の異好坑体吸収処理、等はその
代表例である3、そこで、予め異好坑体を吸収Jべく、
たとえば羊赤血球の細胞脱型を被検血清中に添加してイ
ン−1−3−ベー1−する場合がある。
<Experimental Example> When performing an immunoassay, if a heterophilic antibody of A. fulsun antibody is present in the test serum as a specimen, the immunoassay may not be performed accurately. For example, when measuring hemolysin, a typical example is the absorption treatment of heterophilic antibodies for complement surface clean guinea pigs 1 to 2 (T'i).
For example, detyped sheep red blood cells may be added to the test serum for incubation.

この異好抗体を除去づるために、この発明の方法を使用
する。
The method of this invention is used to remove this heterophilic antibody.

レクグーンとしてコンカブバリンへを用い、これをアミ
ノ基を導入したポリビニルノフル−」−ルに水溶性カル
ボジイミドを用いて固定化した。そこで、採集した被検
血清中に赤血球ゴースト膜を添加して、当該ゴースト膜
に異好抗体を吸収さUた後、ス]−ローマ(蛋白質とし
て5 my )を含む被検血清を1d得、次で前記被検
血清1dに」ンカプバリンAを担持するポリビニルアル
コールを溶解する生理食塩水0.2ml!を添加し、撹
拌後、4℃に冷却して5分間静置した。その結果、ゴー
スト膜が完全に沈降し、ゴースト膜を含まないに澄液を
得ることができた。前記上澄液には一1ンカノ′バリン
Aが含まれていないことも確認できた。
Concabuvaline was used as a lectom, and it was immobilized on polyvinylnofluor into which an amino group had been introduced using water-soluble carbodiimide. Therefore, a red blood cell ghost membrane was added to the collected test serum, and after the heterophilic antibodies were absorbed by the ghost membrane, 1 d of test serum containing S]-Roma (5 my protein) was obtained. Next, add 0.2 ml of physiological saline in which polyvinyl alcohol carrying capvalin A is dissolved in the test serum 1d. After stirring, the mixture was cooled to 4° C. and allowed to stand for 5 minutes. As a result, the ghost film was completely precipitated, and a clear liquid containing no ghost film could be obtained. It was also confirmed that the supernatant liquid did not contain 11-linkerovaline A.

〈比較例〉 前記実験例と同様にして得た血清1−に生理食塩水0.
211117を添加し、撹拌後静置したが、30分を経
過しても−1−スト股が沈降しなかった。
<Comparative Example> Serum obtained in the same manner as in the above experimental example was mixed with 1.0% of physiological saline.
211117 was added and left to stand after stirring, but the -1-strike crotch did not settle even after 30 minutes.

〔発明の効果〕〔Effect of the invention〕

Claims (1)

【特許請求の範囲】[Claims] 細胞を含有する検体と、担体に固定する細胞凝集素とを
接触させることを特徴とする検体からの上澄液生成方法
1. A method for producing a supernatant from a specimen, which comprises bringing a specimen containing cells into contact with a cell agglutinin immobilized on a carrier.
JP449084A 1984-01-12 1984-01-12 Formation of supernatant liquid from specimen Granted JPS60147650A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP449084A JPS60147650A (en) 1984-01-12 1984-01-12 Formation of supernatant liquid from specimen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP449084A JPS60147650A (en) 1984-01-12 1984-01-12 Formation of supernatant liquid from specimen

Publications (2)

Publication Number Publication Date
JPS60147650A true JPS60147650A (en) 1985-08-03
JPH0416744B2 JPH0416744B2 (en) 1992-03-25

Family

ID=11585528

Family Applications (1)

Application Number Title Priority Date Filing Date
JP449084A Granted JPS60147650A (en) 1984-01-12 1984-01-12 Formation of supernatant liquid from specimen

Country Status (1)

Country Link
JP (1) JPS60147650A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS49133597A (en) * 1972-11-06 1974-12-21
JPS57103649A (en) * 1980-12-18 1982-06-28 Asahi Chemical Ind Sterilized gamma-globulin fixing column

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS49133597A (en) * 1972-11-06 1974-12-21
JPS57103649A (en) * 1980-12-18 1982-06-28 Asahi Chemical Ind Sterilized gamma-globulin fixing column

Also Published As

Publication number Publication date
JPH0416744B2 (en) 1992-03-25

Similar Documents

Publication Publication Date Title
JP3110839B2 (en) Method for producing biologically active reagent derived from succinimide-containing polymer, analytical element comprising the same and use thereof
SE443660B (en) PROCEDURE AND REAGENT FOR IMMUNAL ANALYSIS WITH RF OR CLQ ADSORBED TO FIXED BEARERS
EP0468585B1 (en) Biologically active reagent, analytical element and methods for use of the reagent
US3912805A (en) Reagent and assay for human fibrinogen degradation products
EP0194156B1 (en) Method of measuring the amount of immune antibody in serum
CN101046479B (en) Process of preparing human serum base matter containing no target protein
CN114736868B (en) Temperature response functional compound and exosome homogeneous separation and purification method
JPS60147650A (en) Formation of supernatant liquid from specimen
GB1564063A (en) Process for the preparation of -l antibody and -l antigen and preparation and use of reagents containing them
CN106442079B (en) Blood filtration sample pad and preparation method thereof
IE901081L (en) Enzymatic assay kit and method applicable to whole cells
CN111537730A (en) Test paper for detecting brucella antibody
EP0049161B1 (en) Method for preparing sample for use in endotoxin test and kit for preparing said sample
WO1994008239A1 (en) Detection of antigens and nucleic acids
JPH04203967A (en) Rapid measurement method of small amount of constituent
JP2000028612A (en) Immunological inspection method and immunological inspection kit thereof
SU1158029A3 (en) Method of quantitative determination of triiodothyronine
JPH08502413A (en) Method and apparatus for detecting cells
JP3166764B2 (en) Rapid measurement of trace components
JP3463548B2 (en) Protozoan culture method and immunoassay reagent
KR100193267B1 (en) Immune membrane strips and methods of making the same
SU1243731A1 (en) Method of determining immune complexes
JPS606869A (en) Composition agent for separating cell and usage thereof
JPH0456258B2 (en)
CN117517645A (en) Method for separating serum by anti-erythrocyte antibody magnetic particles and application